Introducing Aurora Biologics
Aurora Spine Corporation, a prominent player in the minimally invasive spine market, has recently unveiled its new biologics division—Aurora Biologics. This innovative initiative is committed to improving spinal fusion processes through advanced biologic technologies. With a focus on generating better patient outcomes, Aurora Biologics intends to redefine standards in spinal care.
A Seamless Integration of Technologies
The emergence of Aurora Biologics aligns perfectly with the company’s existing ecosystem of spine solutions. This range includes acclaimed systems such as ZIP™, Hydra A.E.R.O.™, DEXA™, and SiLO™. Together, these systems form a collaborative platform that not only enhances surgical efficiency but also fosters long-term success in spinal fusion procedures.
A Wide Array of Allograft Solutions
Aurora Biologics debuts with a robust collection of allograft solutions, showcasing its commitment to quality and effectiveness. Here are some of the key offerings:
TURBO FUSE™ Fiber Putty
This innovative product is a bone graft substitute designed from demineralized bone fibers. Its unique composition maximizes surface area and promotes cellular attachment for better bone integration in surgical procedures.
OSTEO GRAFT™ DBM Putty
This demineralized cortical bone graft boasts a cohesive and moldable consistency, allowing for effective support in bone formation without relying on synthetic materials.
OSTEO BRIDGE™ Sponge Strips
These sponge-like graft substitutes are specifically crafted to conform to patient anatomy. They are ideal for filling bone voids and facilitating structural regeneration in challenging surgical environments.
Natural Healing with Biologic Innovation
The allograft solutions from Aurora Biologics are formulated entirely from 100 percent allograft bone, ensuring they are free of synthetic carriers. This purity grants them natural osteoconductive and osteoinductive properties, promoting high-quality and reliable bone growth. With the design focus on filling bony defects and augmenting fusion sites, these products establish a natural biologic scaffold essential for effective bone regeneration.
Strengthening Surgical Excellence
What sets Aurora Biologics apart is its synergy with Aurora’s implant technologies. This collaboration creates an advanced, biologically active environment for fusion procedures that can significantly enhance outcomes for both patients and surgeons alike.
Visionary Leadership Insights
Mathew Goldstone, Chief Commercial Officer at Aurora Spine, emphasizes the comprehensive nature of Aurora Biologics. He notes, “Our integrated portfolio allows surgeons to improve patient outcomes with a streamlined approach, covering every phase of the fusion procedure comprehensively.”
In alignment with this vision, Trent J. Northcutt, President & CEO of Aurora Spine, points out that this platform will not only enhance clinical results but will also serve as a significant growth driver for the company. The expectation is for a more than 30 percent increase in the effectivity of their previous biologic offerings, promising stronger margins and acting as a powerful profit engine going forward.
A New Benchmark in Spine Care
Aurora Spine aims to establish a new standard in biologic performance that reflects its motto of “Simplifying the Complex.” These new products are positioned as easy to use, clinically effective, and representative of Aurora Spine’s unwavering commitment to both innovation and quality standards in healthcare.
About Aurora Spine Corporation
Aurora Spine Corporation is a leading designer and manufacturer within the minimally invasive spinal implant arena. With its headquarters in Carlsbad, California, the organization is dedicated to advancing patient care worldwide through cost-effective and efficient surgical solutions. To learn more about their initiatives and product offerings, potential customers can visit their website for further information.
Company Contact Information
Aurora Spine Corporation
Trent Northcutt
President and Chief Executive Officer
Phone: (760) 424-2004
Chad Clouse
Chief Financial Officer
Phone: (760) 424-2004
For investor relations, contact Adam Lowensteiner at Lytham Partners:
Phone: (646) 829-9702
Frequently Asked Questions
What is Aurora Biologics?
Aurora Biologics is a new division of Aurora Spine Corporation focusing on advancing spinal fusion technologies using innovative biologic solutions.
How does Aurora Biologics enhance surgical outcomes?
By integrating biologic products with existing implant technologies, Aurora Biologics aims to create a comprehensive environment that supports optimal healing and promotes bone growth.
What types of products does Aurora Biologics offer?
Aurora Biologics offers several allograft solutions including TURBO FUSE™ Fiber Putty, OSTEO GRAFT™ DBM Putty, and OSTEO BRIDGE™ Sponge Strips.
What is the commitment of Aurora Spine towards innovation?
Aurora Spine is dedicated to simplifying complex spinal procedures while ensuring high-quality patient care through continuous innovation and improved clinical outcomes.
How can I learn more about Aurora Spine's products?
Additional information can be found on the company’s official website, which details their product offerings and company initiatives.
